Lieber Institute for Brain Development

Call Directions Website

Lieber Institute for Brain Development Translating genetic insights into next generation treatments. LIBD partners with academic, pharmaceutical, foundation, and government agencies world-wide.

The Lieber Institute for Brain Development (LIBD) was established in 2010 through the historic gift of Constance & Stephen Lieber and Milton & Tamar Maltz as an independent, not-for-profit medical research institute with end-to-end capabilities under one roof. LIBD translates genetic insights into breakthrough treatments utilizing unparalleled resources in human brain tissue and human cell lines to understand the developmental origins of schizophrenia and related brain disorders. Affiliated with the Johns Hopkins University School of Medicine, LIBD is led by Dr. Daniel Weinberger, formerly the head of the Genes, Cognition and Psychosis Program at the National Institute of Mental Health, and includes a world-class team of scientists with over 200 years’ cumulative experience and 2,500 published scientific papers. The Institute is committed to a collaborative approach and invests in building research networks and partnerships to accelerate scientific discovery.

Congratulations to Heena Divecha, Sang Ho Kwon, Jennifer Kim, Jonathan Werner, and Beau Oster, who each received a Socie...
10/14/2026

Congratulations to Heena Divecha, Sang Ho Kwon, Jennifer Kim, Jonathan Werner, and Beau Oster, who each received a Society for Neuroscience Trainee Professional Development Award (TPDA).

The awards support trainees attending and presenting their research at the Society for Neuroscience annual meeting. Congratulations to all five!

Depression can affect nearly every part of daily life, from sleep and concentration to energy, motivation, and the abili...
10/12/2026

Depression can affect nearly every part of daily life, from sleep and concentration to energy, motivation, and the ability to manage everyday responsibilities.

But depression doesn’t look the same for everyone. Two people can share the same diagnosis yet experience different symptoms, challenges, and patterns of illness. Why? Part of the answer may lie in the underlying biology of the brain.

At the Lieber Institute for Brain Development, researchers study the biological mechanisms behind psychiatric disorders to better understand what makes each condition—and each individual’s experience—unique.

By identifying the distinct biological pathways involved in depression, scientists hope to advance research toward more precise, personalized approaches to treatment in the future.

Understanding the brain is an important step toward understanding depression—and improving the lives of those affected by it.

đź§  World Mental Health Day is a reminder that understanding the brain is an important part of advancing mental health car...
10/10/2026

đź§  World Mental Health Day is a reminder that understanding the brain is an important part of advancing mental health care.

Mental health conditions are complex, and no two people experience them in exactly the same way. That’s why understanding the brain at the molecular and cellular levels is so important.

At the Lieber Institute for Brain Development, researchers are working to uncover the biological mechanisms underlying psychiatric and neurological disorders, including the brain changes that may contribute to conditions such as depression, schizophrenia, and bipolar disorder.

By connecting fundamental neuroscience with the long-term goal of improving mental health care, Lieber’s research helps build the foundation for future discoveries, more targeted treatments, and a deeper understanding of the people behind each diagnosis.

This World Mental Health Day, we recognize the importance of mental health research and the scientists working to turn a greater understanding of the brain into new possibilities for care. ❤️

Meet Geo! đź‘‹Geo Pertea is a bioinformatics scientist who joined the Lieber Institute as a Staff Scientist II in 2020. Dra...
10/07/2026

Meet Geo! đź‘‹

Geo Pertea is a bioinformatics scientist who joined the Lieber Institute as a Staff Scientist II in 2020. Drawing on extensive experience in bioinformatics development and genomic data management, Geo is involved with overseeing the Institute’s data infrastructure and collaborates on grant-funded studies of brain development and neuropsychiatric disorders. He has contributed to the development of well-cited RNA-seq software, including the transcript assembler StringTie. Before joining LIBD, Geo worked as a bioinformatics software engineer at Johns Hopkins University’s Center for Computational Biology. He earned an M.D. from the University of Medicine and Pharmacy “Carol Davila” in Bucharest and an M.S. in Computer Science from Johns Hopkins University.

Stafford’s Legacy: The Nibley Family’s StoryStafford Nibley’s family remembers him for his beautiful singing voice, his ...
10/05/2026

Stafford’s Legacy: The Nibley Family’s Story

Stafford Nibley’s family remembers him for his beautiful singing voice, his love of acting and athletics, and his outgoing yet sometimes shy nature. He was sensitive, intelligent, precocious, and cheerful, and he dreamed of a career in musical theater.

But behind those gifts, Stafford was struggling with severe mental illness and addiction. Over the final 10 years of his life, he participated in 43 rehabilitation and mental health programs and was hospitalized 20 times for self-harm.

In May 2021, Stafford died at age 25 following an overdose and the effects of a lifetime of mental illness.

In the midst of their grief, Stafford’s family received a call from Dr. Thomas Hyde, Chief Medical Officer of the Lieber Institute for Brain Development. He told them about LIBD’s research into the biological and genetic mechanisms that may contribute to mental illness and asked if they would consider donating Stafford’s brain to research.

“There wasn’t a second that we hesitated,” Stafford’s father, Stuart, recalls. “Maybe his struggle and his life were not futile. Maybe he can begin to help advance the understanding of the brain. It gives us a sense of purpose.”

Today, Stafford’s brain is contributing to research aimed at understanding why some individuals remain so vulnerable to mental illness despite accessing available treatments—and how that knowledge could lead to more effective, targeted therapies.

Donor families make the Lieber Institute’s science possible. Families who choose to donate their loved one’s brain to mental health research transform profound loss into an opportunity for discovery.

We hold sacred gratitude for the Nibley family for entrusting LIBD with Stafford’s legacy. Through their generosity, Stafford’s story continues to contribute to scientific discovery and hope for individuals and families impacted by mental illness.

🎓 Congratulations, Aaron Salisbury!Aaron recently presented his public thesis seminar, “Cortistatin as a Common Link Bet...
10/02/2026

🎓 Congratulations, Aaron Salisbury!

Aaron recently presented his public thesis seminar, “Cortistatin as a Common Link Between Stress-related Disorders and Epilepsy.”

This presentation marks an important milestone in Aaron’s research journey and reflects his dedication to advancing our understanding of the biological mechanisms underlying brain and mental health disorders.

Congratulations, Aaron, on this exciting accomplishment! We’re proud to celebrate this milestone with you and look forward to seeing where your research takes you next. 👏

🔬 Congratulations, Suhaas Adiraju!Suhaas recently attended the 2026 Gordon Research Conference on the Frontal Cortex, wh...
09/30/2026

🔬 Congratulations, Suhaas Adiraju!

Suhaas recently attended the 2026 Gordon Research Conference on the Frontal Cortex, where he gave his first scientific talk and presented a poster highlighting his ongoing thesis research.

His presentation, “Characterization of an Amphetamine-Activated Ensemble Relevant for Attention Control in the Medial Prefrontal Cortex,” explored the neural circuits involved in the frontal cortex and attention control.

Sharing research with fellow scientists is an exciting milestone in any researcher’s journey, and we’re proud to celebrate Suhaas as he continues to grow as a scientist.

Congratulations, Suhaas, on this exciting opportunity to share your work with the scientific community!

🎉 Celebrating Kelsey! 🎉The team celebrated Kelsey’s last day as a Research Assistant and wished her well as she begins h...
09/28/2026

🎉 Celebrating Kelsey! 🎉

The team celebrated Kelsey’s last day as a Research Assistant and wished her well as she begins her next chapter.

Thank you, Kelsey, for being part of the Lieber community! ❤️

Lieber scientists ask what happens in the brain that makes some people take their own lives. The Lieber Institute is uni...
09/25/2026

Lieber scientists ask what happens in the brain that makes some people take their own lives. The Lieber Institute is uniquely positioned for this research since many of our postmortem brain collection samples come from people who died by su***de. Those samples are precious in research on su***de because the biology of su***de—the underlying mechanisms that made the su***de possible—is fixed in the brain at the time of death.

Lieber researchers are looking at these biological snapshots of what occurred in the brain at the moment of su***de completion to determine what’s different about these brains. Lieber Institute researchers are even considering different types of su***de to find biological differences and similarities. The Institute’s researchers are working on a potential new treatment to reduce suicidal thoughts and prevent attempts.
“I study su***de as a separate entity with its own specific complexity and phenomenology. Severe anxiety, agitation, and impulsivity may be better indicators of suicidal behavior than a psychiatric diagnosis. There are no pharmacologic treatments to address su***de specifically. It’s imperative that we find ways to protect affected patients from the risk of harming themselves.”

Giovanna Punzi, MD, PhD, Research Scientist

Congratulations to Stephanie Page, Ph.D., on her promotion to Investigator at the Lieber Institute!We’re excited to cele...
09/23/2026

Congratulations to Stephanie Page, Ph.D., on her promotion to Investigator at the Lieber Institute!

We’re excited to celebrate this next step in Stephanie’s career and her continued contributions to research at the Institute.

Address

855 N. Wolfe Street, Suite 300
Baltimore, MD
21205

Alerts

Be the first to know and let us send you an email when Lieber Institute for Brain Development posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share